Literature DB >> 9400504

Vancomycin-resistant Staphylococcus aureus: apocalypse now?

S Tabaqchali1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9400504     DOI： 10.1016/S0140-6736(05)64269-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.

Authors:  Pierre Vaudaux; Asllan Gjinovci; Manuela Bento; Dongmei Li; Jacques Schrenzel; Daniel P Lew
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

2.  Removing intravascular lines at 72 hours allows need for antibiotics to be reassessed.

Authors:  M Ruddy; C C Kibbler
Journal:  BMJ       Date:  1998-06-13

3.  The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.

Authors:  D J Austin; K G Kristinsson; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

4.  Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection.

Authors:  Paul Covington; J Michael Davenport; David Andrae; William O'Riordan; Lisa Liverman; Gail McIntyre; June Almenoff
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

5.  Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models.

Authors:  D J Austin; R M Anderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

6.  Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

Authors:  Jeffrey Fernandez; Darren Abbanat; Wenchi Shang; Wenping He; Karen Amsler; James Hastings; Anne Marie Queenan; John L Melton; Alfred M Barron; Robert K Flamm; A Simon Lynch
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

7.  Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections.

Authors:  J P Burnie; R C Matthews; T Carter; E Beaulieu; M Donohoe; C Chapman; P Williamson; S J Hodgetts
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 8.  Diagnosis and management of osteomyelitis. Decision analytic and pharmacoeconomic considerations.

Authors:  M Tavakoli; P Davey; B A Clift; H T Davies
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981

Review 9.  Peritoneal dialysis. Prevention and control of infection.

Authors:  R Gokal
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

10.  Peritonitis associated with vancomycin-resistant Lactobacillus rhamnosus in a continuous ambulatory peritoneal dialysis patient: organism identification, antibiotic therapy, and case report.

Authors:  G Klein; E Zill; R Schindler; J Louwers
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.